FDA Clearance Tracker · P790017
USCI DILATATION CATHETER
Last checked: Nov 19, 2026Latest source record: Mar 24, 1980 (this decision)Source: openFDAMethods & limitations
Decided
Mar 24, 1980
Approved (reclassified)
Time to decision
283 days
Received Jun 15, 1979. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class II
The decision
- FDA number
- P790017
- Device name
- USCI DILATATION CATHETER
- Applicant
- Medtronic, Ireland
- Applicant location
- Galway
- Received
- Jun 15, 1979
- Decided
- Mar 24, 1980
- Decision
- Approved (reclassified)
- Supplements
- 86 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.5100
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code LOX (Catheters, transluminal coronary angioplasty, percutaneous).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic, Ireland
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261428 · Decided Aug 14, 2026 · 106 days after receipt
Device type: Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX) · Cardiology
K261759 · Decided Jul 27, 2026 · 60 days after receipt
Device type: Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX) · Cardiology
K251970 · Decided Jan 17, 2026 · 205 days after receipt
Device type: Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.